Aryl-amino substituted pyrrolopyrimidine multi-kinase...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/185 (2006.01) A61K 31/437 (2006.01) A61K 31/519 (2006.01) A61K 31/5355 (2006.01) A61K 31/541 (2006.01) A61K 31/55 (2006.01) A61K 31/5513 (2006.01) C07D 223/04 (2006.01) C07D 295/02 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2575808

Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mekl, PDK-1, GSK3~, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-lR, Ron, Ret, and KDR kinases in animals, including humans, for the treatment and/or prevention of various diseases and conditions such as cancer.

La présente invention a trait à des composés de formule (I), ou leurs stéréoisomères ou sels pharmaceutiquement acceptables, inhibiteurs d'au moins deux parmi les kinases Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mekl, PDK-1, GSK3ß, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-lR, Ron, Ret, et KDR chez des animaux, comprenant les humains, pour le traitement et/ou la prévention de diverses maladies et conditions telles que le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl-amino substituted pyrrolopyrimidine multi-kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl-amino substituted pyrrolopyrimidine multi-kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-amino substituted pyrrolopyrimidine multi-kinase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647705

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.